What is the HBP.TO share price today?

This page shows the latest available Helix BioPharma Corp. (HBP.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Helix BioPharma Corp. listed?

Helix BioPharma Corp. trades on the Toronto Stock Exchange under the symbol HBP.TO, ISIN CA4229102088.

How large is Helix BioPharma Corp.?

Its market capitalisation is approximately 110.75M CAD, based on the latest available price and share count from our data provider.

Toronto Stock Exchange (TSX) · HBP.TO · ISIN CA4229102088

Helix BioPharma Corp.

1.45 CAD

+0.05(+3.57%)

Previous close · Sep 18, 10:08 ET

Data last updated: Sep 18, 10:08 ET (1 d ago)· Delayed exchange data

Helix BioPharma Corp. (HBP.TO) trades on the Toronto Stock Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 110.75M CAD. The company reports around 7 employees. Its ISIN is CA4229102088. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Toronto Stock Exchange (TSX)

ISIN

CA4229102088

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

110.75M CAD

Employees

Previous close

1.40 CAD

Day range

1.45 – 1.45

52-week range

1.10 – 5.40

Volume

100

50-day average

1.64 CAD

200-day average

1.82 CAD

Asset type

Equity

About Helix BioPharma Corp.

Based in Richmond Hill, Canada, Helix BioPharma Corp. is a Canadian immune-oncology company focused on therapeutic development. The firm is progressing L-DOS47 for treating non-small cell lung cancer and is also working on V-DOS47, which targets the vascular epithelial growth factor receptor 2. Helix BioPharma has formed strategic alliances, including one with Moffitt Cancer Center to analyze L-DOS47's pharmacodynamics and assess the benefits of integrating it with immune checkpoint inhibitors. Another partnership, with ProMab Biotechnologies, Inc., is dedicated to creating innovative antibody and chimeric antigen receptor T-cell therapies to combat multiple myeloma. Furthermore, the company maintains licensing agreements with Xisle Pharma Ventures Trust and the National Research Council Canada.

Company website

Frequently asked

What is the HBP.TO share price today?: This page shows the latest available Helix BioPharma Corp. (HBP.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Helix BioPharma Corp. listed?: Helix BioPharma Corp. trades on the Toronto Stock Exchange under the symbol HBP.TO, ISIN CA4229102088.
How large is Helix BioPharma Corp.?: Its market capitalisation is approximately 110.75M CAD, based on the latest available price and share count from our data provider.

All Helix BioPharma Corp. data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.